Kwality Pharmaceuticals Ltd (KWAL)

Currency in INR
4,128.40
-158.20(-3.69%)
Closed·
KPL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
4,106.504,282.00
52 wk Range
1,561.004,299.00
Key Statistics
Bid/Ask
4,119.00 / 4,128.40
Prev. Close
4,286.6
Open
4,227.8
Day's Range
4,106.5-4,282
52 wk Range
1,561-4,299
Volume
43.62K
Average Volume (3m)
46.38K
1-Year Change
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
KPL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral

Kwality Pharmaceuticals Ltd Earnings Call Summary for Q2/2027

  • Q2 FY27 revenue surged 63% YoY to INR 181 crore; profit after tax doubled to INR 50 crore with EBITDA margin expanding to 27.5%.
  • Full-year revenue guidance raised to INR 720+ crore from INR 700 crore, with management indicating INR 750 crore is achievable.
  • Strong earnings driven by improved product mix and operating leverage; stock trades at low P/E relative to near-term growth prospects.
  • Shares declined 2.3% to INR 3,857.8 despite robust results, though stock remains near 52-week high with strong annual returns.
Last Updated: 2026/11/13, 13:48
Read Full Transcript

Earnings

Latest Release
Nov 12, 2026
EPS / Forecast
27,93 / --
Revenue / Forecast
1,82B / --
EPS Revisions
Last 90 days

KPL Income Statement

Compare KPL to Peers and Sector

Metrics to compare
KPL
Peers
Sector
Relationship
P/E Ratio
44.7x36.4x−0.2x
PEG Ratio
0.470.890.00
Price/Book
11.1x4.1x2.6x
Price / LTM Sales
6.9x4.3x2.6x
Upside (Analyst Target)
-13.7%76.9%
Fair Value Upside
Unlock5.5%14.9%Unlock

Kwality Pharmaceuticals Limited, together with its subsidiary, manufactures finished pharmaceutical formulations in India and internationally. The company offers its products in various dosage forms, including capsules, eye and ear drops, ointments and creams, pouches and sachets, sanitizers, tablets, suppositories, injectable vials and ampoules, liquid orals, lyophilized products, syrups, and various other categories, such as general, beta-lactam, cephalosporins, oncology, biologics, and hormones and specialty injectables. It also provides intermediates, chemicals, extracts, alkaloids, toilet requisites, beverages, and other medical preparations. Kwality Pharmaceuticals Limited was incorporated in 1983 and is based in Amritsar, India.

Employees
1137
Market
India

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
184,000,00%759,63K
Other Institutional Investors
538,33K5,19%2,22B
Public Companies & Retail Investors
9,84M94,81%40,61B
Total
10,38M100,00%42,84B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Ark Global Emerging Companies, LP2,11%218 896903 690
Seven Canyons Advisors, LLC2,11%218 896903 690

FAQ

What Is the Kwality Pharmaceuticals (KPL) Stock Price Today?

The Kwality Pharmaceuticals stock price today is 4 128,40 INR.

What Stock Exchange Does Kwality Pharmaceuticals Trade On?

Kwality Pharmaceuticals is listed and trades on the India National Stock Exchange.

What Is the Stock Symbol for Kwality Pharmaceuticals?

The stock symbol for Kwality Pharmaceuticals is "KPL."

What Is the Kwality Pharmaceuticals Market Cap?

As of today, Kwality Pharmaceuticals market cap is 42,91B INR.

What Is Kwality Pharmaceuticals's Earnings Per Share (TTM)?

The Kwality Pharmaceuticals EPS (TTM) is 92,46.

From a Technical Analysis Perspective, Is KPL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Kwality Pharmaceuticals Stock Split?

Kwality Pharmaceuticals has split 0 times.

How Many Employees Does Kwality Pharmaceuticals Have?

Kwality Pharmaceuticals has 1137 employees.

What is the current trading status of Kwality Pharmaceuticals (KPL)?

As of Nov 21, 2026, Kwality Pharmaceuticals (KPL) is trading at a price of 4 128,40 INR, with a previous close of 4 286,60 INR. The stock has fluctuated within a day range of 4 106,50 INR to 4 282,00 INR, while its 52-week range spans from 1 561,00 INR to 4 299,00 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.